Carregant...
Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques
BACKGROUND: Anti-CD2 treatment provides targeted immunomodulatory properties that have demonstrated clinical usefulness to condition the immune system and to treat transplant rejection. The treatment is species-specific due to structural CD2 antigen differences between non-human primates and humans....
Guardat en:
| Publicat a: | Transpl Int |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017722/ https://ncbi.nlm.nih.gov/pubmed/31523849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13524 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|